Diana Do, MD, professor of ophthalmology and vice chair for clinical affairs, Byers Eye Institute, Stanford University, discusses real-world data presented at the American Academy of Ophthalmology showing…
Richard Gale, MBChB, PhD, professor of ophthalmology, Hull York Medical School, UK, presents long-term real-world outcomes of intravitreal aflibercept 8 mg in patients with diabetic macular edema. Over…
NEW YORK (Reuters Health) – Propranolol is a safe treatment for severe infantile hemangiomas that can markedly shorten the disease course, according to findings from a small study…
C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Residency Program Director, Director of Ophthalmic Plastics and Reconstructive Surgery Service, Yale University, discusses eye surgery transitioning from the…
C. Robert Bernardino, MD, FACS, Associate Professor of Ophthalmology, Residency Program Director, Director of Ophthalmic Plastics and Reconstructive Surgery Service, Yale University, discusses thyroid eye disease, which is…
NEW YORK (Reuters Health) – The results of a 30-year study indicate that intensive glucose control can substantially reduce the rates of retinopathy, nephropathy, and cardiovascular disease in…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses retinoblastoma and the importance of germline vs somatic mutations in predicting prognosis. Summary: Retinoblastoma can be…
Hylton Mayer, MD, Assistant Clinical Professor, Yale University Department of Ophthalmology, discusses presbyopia correcting artificial lenses which, when used at the time of cataract surgery, help a patient…
Jonathan Sears, MD, Associate Professor of Ophthalmology, Cole Eye Institute, Cleveland Clinic, discusses reversing phase 1 and 2 of ROP by turning down oxygen levels to encourage retinal…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses metastatic eye cancer that can be caused by any cancer, but most commonly carcinomas. Summary: Breast…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses retinoblastoma and treatment options, which include enucleation and radiation, chemotherapy, cryotherapy and TTT (transpulillary thermotherapy protocol).…
Miguel Materin, MD, Director of Ocular Oncology Section, Yale Eye Center, discusses chromosomal analysis within a tumor, the most important guide to clinical survival. Summary: Chromosal analysis of…
